	Kısa Vadeli Yükümlülükler		Tarih
AbbVie	USD 39.39B	376M	2025-09
Amgen	USD 25.49B	3.7B	2025-12
Anika Therapeutics	USD 19.09M	3.01M	2025-09
Arrowhead Research	USD 347.42M	151.94M	2025-12
AstraZeneca	USD 34.05B	518M	2025-09
BioCryst Pharmaceuticals	USD 190.24M	13.08M	2025-09
Biogen	USD 3.35B	59.4M	2025-12
Bristol-Myers Squibb	USD 28.14B	608M	2025-09
Enanta Pharmaceuticals	USD 48.56M	4.01M	2025-09
Gilead Sciences	USD 12.3B	1.11B	2025-09
GlaxoSmithKline	GBP 21.39B	57M	2025-12
Halozyme Therapeutics	USD 837.23M	702.95M	2025-09
Heron Therapeutics	USD 89.71M	168.89M	2025-09
Immunic	USD 30.08M	2.77M	2025-09
Incyte	USD 1.52B	176.44M	2025-12
Insmed	USD 417.21M	105.53M	2025-09
Ionis Pharmaceuticals	USD 903.46M	6.22M	2025-09
J&J	USD 50.87B	3.31B	2025-09
Karyopharm Therapeutics	USD 87.16M	12.06M	2025-09
Ligand Pharmaceuticals	USD 30.54M	34.2M	2025-09
Merck	USD 28.63B	2.59B	2025-09
Neurocrine Biosciences	USD 638M	91.7M	2025-09
Novartis	USD 32B	286M	2025-09
Novavax	USD 429.87M	40.73M	2025-09
Pfizer	USD 36.6B	1.13B	2025-09
PTC Therapeutics	USD 866.24M	238.44M	2025-09
Roche Holding	CHF 28B	421M	2025-12
Sarepta Therapeutics	USD 921.42M	1.48M	2025-09
Vertex Pharmaceuticals	USD 4.48B	336.9M	2025-09

Enanta Pharmaceuticals Kısa Vadeli Yükümlülükler - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Feb 2026.